Last reviewed · How we verify
NCT04074083
An Evaluation of the Effectiveness of e-IMCI Implementation in Primary Health Care Clinics in South Africa.
NA trial testing electronic IMCI in Child Health in 291 participants. Completed in 1 November 2022.
18 June 2021
Quick facts
| Lead sponsor | University of KwaZulu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 291 |
| Start date | 22 January 2021 |
| Primary completion | 18 June 2021 |
| Estimated completion | 1 November 2022 |
| Sites | 1 location across South Africa |
Drugs / interventions tested
- electronic IMCI
- paper IMCI
Conditions studied
- Child Health — all drugs for Child Health →
- Clinical Practice Guidelines — all drugs for Clinical Practice Guidelines →
- Primary Health Care — all drugs for Primary Health Care →
Sponsor
University of KwaZulu
Who can join
Adults 2 Months to 59 Months, any sex, with Child Health or Clinical Practice Guidelines. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research hypothesis is that sick children attending primary health care (PHC) clinics who are managed by IMCI-trained health workers (HWs) using electronic Integrated Management of Childhood Illness guidelines (e-IMCI) receive better quality of care compared to children managed by HWs using conventional paper-based IMCI (pIMCI). The aim of the study is to evaluate the effectiveness of e-IMCI to improve care for sick children under five years attending PHC clinics in one district in KwaZulu-Natal, South Africa. Objectives: 1. To assess feasibility and acceptability of eIMCI implementation in PHC clinics 2. To compare clinic-based management of sick children using e-IMCI with a gold standard IMCI assessment, and those managed using p-IMCI to a gold standard IMCI assessment 3. To determine the cost effectiveness of e-IMCI compared to p-IMCI implementation in PHC clinics Primary outcomes: * Proportion of sick children receiving all medications indicated among children managed by HWs using eIMCI and HWs using pIMCI. * Proportion of sick children with risk/high risk of Tuberculosis, HIV or HIV exposed, and/or malnutrition correctly identified among children assessed using eIMCI and children assessed using pIMCI, compared to a gold standard IMCI assessment. * Incremental cost-effectiveness of eIMCI implementation vs standard of care (pIMCI). The study will employ a prospective two-arm cluster randomized controlled trial. Sample size: a total of 30 clinics in one district will be randomly selected to participate and allocated to the intervention (eIMCI) group (n=15) and control (pIMCI) group (n=15). One IMCI trained HW will be randomly selected from each clinic to participate. Six observations will be conducted with each participating health worker Intervention HWs will receive an IMCI update and computer training based on eIMCI. Control HWs will receive a similar update using pIMCI. Both groups will receive support visits and intervention HWs will receive additional computer/IT support. Health worker knowledge will be assessed pre and post training using a self-administered questionnaire. Quality of care will be assessed in both groups using exit interviews with mothers and review of child health records. In addition, gold standard IMCI assessments will be conducted by an IMCI expert to determine correct findings. Assessment and management of the child by the IMCI expert will be compared to that of the participating HW to determine quality of care provided.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04074083
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Child Health
Currently open trials in the same condition.
- NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
- NCT06969248 — Program to Increase Fathers' Involvement in Infant Care · NA · active not recruiting
- NCT06593080 — The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis · NA · recruiting
- NCT06185413 — Children's Cooperation Denmark: a 3-year System Dynamics Trial · NA · active not recruiting
Other University of KwaZulu trials
Trials by the same sponsor.
- NCT07339462 — Feasibility and Acceptability of an Intervention to Support People With Severe Mental Illness in South Africa · NA · recruiting
- NCT06516549 — Evaluation of Skipping Rope and Informational Pamphlet Among Adolescents in South Africa · NA · recruiting
- NCT06429475 — Anti-Inflammatory Reliever South Africa · Phase 3 · recruiting
- NCT06248190 — ENHANCE-EvideNce Led Co-created HeAlth Systems interventioNs for MLTCs CarE · NA · completed
- NCT05061407 — An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Paediatric Patients Undergoing Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04074083 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of KwaZulu
- Last refreshed: 4 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04074083.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing